ロード中...
In-Vitro Application of Magnetic Hybrid Niosomes: Targeted siRNA-Delivery for Enhanced Breast Cancer Therapy
Even though the administration of chemotherapeutic agents such as erlotinib is clinically established for the treatment of breast cancer, its efficiency and the therapy outcome can be greatly improved using RNA interference (RNAi) mechanisms for a combinational therapy. However, the cellular uptake...
保存先:
| 出版年: | Pharmaceutics |
|---|---|
| 主要な著者: | , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8002368/ https://ncbi.nlm.nih.gov/pubmed/33809700 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics13030394 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|